Introduction: Primary malignant pericardial mesothelioma is a very rare pericardial tumor of unknown etiology.
Introduction
Primary malignant pericardial mesothelioma is a very rare pericardial tumor of unknown etiology.
Case presentation
A 61-year-old Caucasian woman was admitted to our hospital complaining of exertional dyspnea (NYHA III) and chest pain. Transthoracic echocardiography demonstrated a large pericardial effusion. Pericardiocentesis revealed 1500 ml of an acellular, sterile pericardial effusion and symptoms were markedly relieved.
The patient was re-admitted three months later, and transthoracic echocardiography showed a recurrent large pericardial effusion with partly organized fibrinous structures inside the effusion. There were no signs of cardiac tamponade, but there was a thickened right ventricular pericardium ( This was considered to be a PMPM because no signs of a pleural mesothelioma were found. Despite the abovementioned findings of the magnetic resonance imaging (MRI) scan of the chest, FDG-PET, echocardiography and pericardiocentesis, we suspected PMPM but could not definitively declare a preoperative diagnosis of PMPM.
Subsequently, four cycles of chemotherapy with pemetrexed and cisplatin (four cycles in four months -dosage according to recently published trials) were administered, and remission was achieved [2] [3] [4] [5] . The patient remained asymptomatic, and there was no recurrence of the tumor during the next three years.
Discussion
Diagnosis of pericardial diseases can be challenging and often requires a multimodal imaging approach including echocardiography, MRI, CT and FDG-PET scans [6, 7] . The majority of reported pericardial tumors are metastatic in nature and indicate a poor prognosis. Primary tumors of the pericardium are extremely rare, and PMPM is a very rare pericardial tumor of unknown etiology [8] [9] [10] . So far, about 350 cases have been reported in the literature, and in an epidemiological survey, the annual incidence of PMPM was reported to be one in 40 million (incidence 0.0022%). PMPM is characterized by atypical solid growth of the mesothelium with formation of atypical cavities surrounded by fibrous stroma.
There is some recent evidence that asbestos may have a harmful effect on pericardial serosa. However, there has not yet been any definite proven association between asbestos exposure and pericardial disease [2, [8] [9] [10] . Interestingly, our patient had a history of asbestos exposure at work (she worked in a school building).
PMPM is often discovered late during a patient's clinical course or at autopsy. Frequent clinical diagnoses refer mainly to acute pericarditis, constrictive pericarditis, and cardiac tamponade and sometimes to various types of coronary heart disease. Surgical resection remains the main treatment modality in PMPM. The prognosis of this disease remains extremely poor due to its late presentation, inability of complete tumor eradication by surgery and the poor response of PMPM to radiotherapy or chemotherapy. A median survival time from the onset of symptoms is six months [8] [9] [10] . Recently, newer chemotherapeutic regimens after complete excision of the tumor have shown prolonged survival times [2] [3] [4] [5] .
Conclusion
PMPM should be considered and managed appropriately in non-responders to pericardiocentesis or pericardial window for treatment of pericardial effusion or tamponade, and in patients who develop constrictive pericarditis late in their clinical course.
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